window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : May 13, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Featured

  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Genomics and sequencing,Therapeutic Areas

    23andMe study links genetics to GLP-1 weight loss outcomes and side effects

    This Nature-published study from the 23andMe Research Institute identifies genetic [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Drug Discovery & Development

    Circio raises NOK 250M in oversubscribed private placement to advance circRNA gene therapy platform

    Circio has raised NOK 250 million in a significantly oversubscribed [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    SonoNeu exits stealth as part of $41.3M ARPA-H programme to advance sonogenetics

    SonoNeu has emerged from stealth as part of a $41.3m [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    BridgeBio submits FDA NDA for BBP-418 in limb-girdle muscular dystrophy type 2I/R9

    BridgeBio Pharma has submitted a New Drug Application (NDA) to [...]

    May 5, 2026
  • Clinical & Regulatory,Therapeutic Areas

    Chiesi gains CHMP backing for lomitapide in children with rare cholesterol disorder

    Chiesi Global Rare Diseases has received a positive CHMP opinion [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics

    Levicept reports Phase 2 osteoarthritis data in The Lancet showing pain reduction with LEVI-04

    Levicept has reported Phase 2 clinical trial results for LEVI-04 [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development

    Nuclera launches GPCR nanodisc panel to address membrane protein bottleneck in drug discovery

    Nuclera has launched a nanodisc panel designed to improve the [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Manufacturing & Supply Chain,Therapeutic Areas

    Mestag Therapeutics raises $40M and adds leadership ahead of cancer trial

    Mestag Therapeutics has raised $40 million and appointed two senior [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Opinion & Events

    Strong scientists: PHARMExcel’s Margaret Irwin on clinical research careers and early stage trials

    From hospital haematology to leading early stage clinical trials, Margaret [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Therapeutic Areas

    Hemab Therapeutics wins FDA breakthrough therapy status for sutacimig in Glanzmann thrombasthenia

      The FDA has granted breakthrough therapy designation to Hemab [...]

    May 5, 2026
Previous123Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • ARTCLINE completes enrolment in septic shock trial for ARTICE therapy
    Categories: Advanced Therapies, Biotech & Pharma Business, Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
  • SGD Pharma highlights GLP-1 demand, supply chain pressure and sustainability focus at DCAT Week
    Categories: Biotech & Pharma Business, Manufacturing & Supply Chain, Pharmaceuticals and therapeutics
  • ISS National Lab research advances DNA-inspired cancer nanomaterials for chemotherapy and immunotherapy development
    Categories: Drug Delivery & Formulation, Drug Discovery & Development, Pharmaceuticals and therapeutics, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top